speaking to cnbc earlier, the ceo ruled out a merger deal with swiss rival cengenta. >> cengenta is not a logical partner for bayer. both cengenta and bayer are very strong in what's called chemical crop protections, herbicides, insecticides insecticides, fungicides to fight off disease for the crops. that is not a large call target. >>> market share isbarclays is getting a boost after the ceo was fired a week ago. kathleen bum joins us around the desk. the focus on what they're going to be on what they're doing. >> the need for speed at barclays does seem to be what has driven anthony jenkins, the chief executive, who was ousted a few weeks ago out of his seat. nothing today on who's expected to take over from him. they seem to be reluctant to put a time frame on a new chief executive. executive chairman john mcfarland seems to be ramping up the progress of that strategy and the cuts. he says he wants to remove the noncore assets from 57 billion today to 20 billion by the end of 2017. that seems like a huge amount of selloff. while they haven't been too successful in executing that so